Employees engaged in the manufacture and processing of a drug product lack the training and experience required to perform their assigned functions.
See every finding in this document View official sourceBy Category
Training and personnel Findings
in this category 640 findings drawn from 610 published documents. The most recent cases are below; the full set is in search.
See all Training and personnel findingsWhich agency cited it
Companies with the most findings
Recent findings
There is an inadequate number of personnel to manufacture and test APIs adequately.
See every finding in this document View official sourcePersonnel were observed moving quickly in a critical area or in an area immediately adjacent to a critical area likely causing disruption of unidirectional airflow.
See every finding in this document View official sourceThe training of personnel before new or revised standard operating procedures were implemented was inadequate.
See every finding in this document View official sourceProduction personnel were not practicing good sanitation and health habits.
See every finding in this document View official sourceEmployees are not given training in the particular operations they perform as part of their function and current good manufacturing practices.
See every finding in this document View official sourceNarrow by agency
Other categories
These findings are a record of the moment each document was published. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out — do not read them as the current state; check the regulator's official announcements for the latest status. Counts are measured from public data as of 2026-09-04, and findings are extracted automatically from the regulator's published documents. “View official source” on each case links directly to that document.
